Nome Químico: 2,2'-(((3aS,3a'S,4R,4'R,6S,6aR,6'S,6a'R)-((2,7-bis(propylthio)pyrimido[4,5-g]pteridine-4,9-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)
Sorrisos: CCCSC1=NC(N[C@@H]2[C@@H](OC(C)(C)O3)[C@@H]3[C@H](OCCO)C2)=C4C(N=C5C(N[C@@H]6[C@@H](OC(C)(C)O7)[C@@H]7[C@H](OCCO)C6)=NC(SCCC)=NC5=N4)=N1
Inchi: InChI=1/C18H31NO/c1-2-3-4-5-6-7-8-16-9-11-17(12-10-16)13-14-18(19)15-20/h9-12,18,20H,2-8,13-15,19H2,1H3
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42